Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | UNK | UT8408MA | OT / LA |
they administered the fluzone tri (pf) to a staff member but noticed afterwards, that one was expired with no adverse event; Initial information received on 01-Oct-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 47 years old female patient was administered the influenza USP trival A-B subvirion no preservative vaccine [Fluzone] but noticed afterwards, that one was expired with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitants: None On 01-Oct-2025, the patient received a dose of 0.5 ml once of suspect the influenza USP trival A-B subvirion no preservative vaccine (Suspension for injection) (lot: UT8408MA; expiry date: 30-Jun-2025; strength: standard) via intramuscular route in the left deltoid for Immunisation but noticed afterwards, that one was expired with no adverse event (expired product administered) (latency: same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.